LPL Financial
MIST icon

LPL Financial’s Milestone Pharmaceuticals MIST Stock Holding History

LPL Financial’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Buy
193,373
+50,910
+36% +$89.1K ﹤0.01% 5391
2025
Q4 		$288K Buy
142,463
+47,163
+49% +$102K ﹤0.01% 5173
2025
Q3 		$191K Buy
95,300
+84,250
+762% +$148K ﹤0.01% 5362
2025
Q2 		$21.4K Sell
11,050
-100,490
-90% -$134K ﹤0.01% 5464
2025
Q1 		$89.2K Buy
+111,540
New +$222K ﹤0.01% 5068

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

LPL Financial's MIST Position: Q1 2026 in Review

LPL Financial increased its Milestone Pharmaceuticals (MIST) stake by 36% in Q1 2026, buying an estimated $89.1K and bringing the position to 193,373 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #5391.

LPL Financial first reported a position in MIST in Q1 2025 and has held it in 5 quarters since. The position peaked at $288K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • LPL Financial held 193,373 shares of Milestone Pharmaceuticals worth $230K as of Q1 2026.
  • LPL Financial bought 50,910 Milestone Pharmaceuticals shares in Q1 2026, an estimated $89.1K.
  • Milestone Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5391 holding.
  • LPL Financial first reported a position in Milestone Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • LPL Financial's Milestone Pharmaceuticals position peaked at $288K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.